Coronary Heart Disease Clinical Trials

Find Coronary Heart Disease Clinical Trials Near You

The Effect of Cardiac Rehabilitation on Oxidative DNA Damage and Inflammation in Patients With Coronary Artery Disease

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of this study was to determine the levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), an indicator of oxidative stress, and to demonstrate oxidative DNA damage in cardiac rehabilitation treatment in patients with coronary artery disease. Additionally, proinflammatory cytokines TNFα, IL-1β, and IL-6 levels were measured to evaluate the significance of cardiac rehabilitation treatment in patients with coronary artery disease and to assess the correlation between cytokine levels and 8-OHdG levels.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Patients aged 18-65 years with a diagnosis of coronary artery disease and no contraindications to cardiac rehabilitation and exercise testing

• Patients who will undergo cardiopulmonary exercise testing before cardiac rehabilitation

• Patients whose cognitive status is sufficient to complete the study and who can cooperate

• 18 years of age or older

• Not having a chronic disease (such as uncontrolled diabetes mellitus, hypertension, heart and kidney failure)

• Not taking regular medication

Locations
Other Locations
Turkey
Erciyes University Faculty of Medicine
RECRUITING
Kayseri
Contact Information
Primary
Hasan KARA, M.D.
drhasankara@yandex.com
+905552592665
Time Frame
Start Date: 2025-05-15
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 70
Treatments
Experimental: Study group for cardiac rehabilitation with coronary artery disease
Individuals diagnosed with coronary artery disease will engage in a programme of cardiac rehabilitation.
No_intervention: Healthy control group
Related Therapeutic Areas
Sponsors
Leads: TC Erciyes University

This content was sourced from clinicaltrials.gov